Skip to main content

Find Clinical Trials

Home
Conditions
Tetanus

Clinical trial condition

Tetanus

Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.

272 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Tetanus trial results

Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

NCT01546909

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: SPMSD Investigational Site 120 Angers, France

SPMSD Investigational Site 103 Arras, France

SPMSD Investigational Site 155 Asnières, France

SPMSD Investigational Site 125 Bersée, France

View all 45 locations

View Trial Details

Completed

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

NCT01249183

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: Sanofi Pasteur MSD Investigational Site Angers, France

Sanofi Pasteur MSD Investigational Site Châtellerault, France

Sanofi Pasteur MSD Investigational Site Clermont-Ferrand, France

Sanofi Pasteur MSD Investigational Site Gières, France

View all 20 locations

View Trial Details

Completed

REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children

NCT00447525

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: Albertville, France

Albi, France

Angers, France

Annecy, France

View all 64 locations

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

NCT01767376

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +14 more
Locations: GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany

GSK Investigational Site Bindlach, Bavaria, Germany

View all 15 locations

View Trial Details

Completed

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

NCT00473668

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Kolkotta, India

GSK Investigational Site Varanasi, India

View Trial Details

Completed

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

NCT02538211

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +14 more
Locations: Academic Medical Center Amsterdam, North Holland, Netherlands

View Trial Details

Completed

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

NCT01457495

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

NCT01457508

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Not specified

View Trial Details

Completed

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

NCT00158808

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old

NCT02089347

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Aichi, Japan

Chiba, Japan

Fukui, Japan

Fukui, Japan

View all 19 locations

View Trial Details